Annual report pursuant to Section 13 and 15(d)

ACQUISITION (Details Narrative)

v3.8.0.1
ACQUISITION (Details Narrative) - USD ($)
2 Months Ended 12 Months Ended
Dec. 31, 2017
Dec. 31, 2017
Dec. 31, 2016
Revenue   $ 1,077,550 $ 671,863
Net loss   (4,171,807) (405,983)
Acquisition related costs   101,236  
Impairment loss   (1,321,338)
Goodwill [Member]      
Impairment loss   $ (397,569)  
Beijing GenExosome      
Revenue $ 26,276    
Net loss $ 30,327